Yeşim Parman - Concepedia

Author

Yeşim Parman

Also Known As

Acary Souza Bulle Oliveira, Ina Giegling, Jeeyoung Oh, Juan González Moreno, Leo McCluskey, Marco Luigetti, Maria del Mar Saniger Alba, Rayomand Press, Valeria Lujan Salutto, Y Parman

220

Publications

10.3K

Citations

H-Index

113

Concepts

All Affiliations

Istanbul University Boğaziçi University University of Antwerp Hacettepe University VIB-UAntwerp Center for Molecular Neurology

About

Yeşim Parman is an author at Istanbul University specializing in medicine, neuropathology, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	37	3.9K
2	Health Sciences	4	4	229
3	Social Sciences	4	4	189
4	Allergy	3	3	271
5	Public Health	1	1	18

Yeşim Parman

Publications

8.4K

Citations

H-Index

Page 1

	Year	Citations
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis David Adams, Alejandra González‐Duarte, William O’Riordan, New England Journal of Medicine	2018	2.8K
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A Stephan Züchner, Irina Mersiyanova, M. Muglia, Nature Genetics Neurodegenerative DiseasesMolecular NeuroscienceMitochondrial FunctionMitochondrial DynamicGenetics	2004	1.5K
A Drosophila Genetic Resource of Mutants to Study Mechanisms Underlying Human Genetic Diseases Shinya Yamamoto, Manish Jaiswal, Wu‐Lin Charng, Cell Drosophila Genetic ResourceGenetic DiseasesGeneticsGenomic MechanismGenetic Mechanism	2014	386
Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy Claudia Gonzaga‐Jauregui, Tamar Harel, Tomasz Gambin, Cell Reports	2015	240
Mutations in a Gene Encoding a Novel SH3/TPR Domain Protein Cause Autosomal Recessive Charcot-Marie-Tooth Type 4C Neuropathy Jan Senderek, Carsten Bergmann, Claudia Stendel, The American Journal of Human Genetics Neurodegenerative DiseasesMolecular NeuroscienceMendelian DisorderGenetic DisorderGenetics	2003	210
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy Teresa Coelho, Wilson Marques, Noel R. Dasgupta, JAMA	2023	171
Transcriptional regulator PRDM12 is essential for human pain perception Ya-Chun Chen, Michaela Auer‐Grumbach, Shinya Matsukawa, Nature Genetics Pain SyndromeSignal TransductionHealth SciencesPain MedicineMolecular Pain	2015	170
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf, The Lancet Neurology Late-onset Pompe DiseaseAutoimmune DiseaseClinical Infectious DiseaseMedicinePhase 3	2021	169
Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis Feza Deymeer, Özlem Güngör–Tunçer, Vuslat Yılmaz, Neurology Muscle FunctionAllergyAutoimmune DiseaseSkeletal MusclePhysiology	2007	166
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study David Adams, Michael Polydefkis, Alejandra González‐Duarte, The Lancet Neurology Alzheimer's DiseaseOpen-label Extension StudyMedicineHereditary Transthyretin-mediated AmyloidosisNeurology	2020	154

Page 1